FGF-2 Protein (bFGF)
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">FGF-2 Protein (bFGF)</th>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Expression in Brain</td>
</tr>
<tr>
<td class="label">FGFR1</td>
<td>[Neurons](/entities/neurons), glia</td>
</tr>
<tr>
<td class="label">FGFR2</td>
<td>Limited</td>
</tr>
<tr>
<td class="label">FGFR3</td>
<td>[Astrocytes](/entities/astrocytes)</td>
</tr>
<tr>
<td class="label">FGFR4</td>
<td>Lower levels</td>
</tr>
<tr>
<td class="label">FGF</td>
<td>Alternative Name</td>
</tr>
<tr>
<td class="label">FGF2 (FGF-2)</td>
<td>bFGF</td>
</tr>
<tr>
<td class="label">FGF9</td>
<td>Neurturin</td>
</tr>
<tr>
<td class="label">FGF18</td>
<td>FGF-18</td>
</tr>
<tr>
<td class="label">FGF21</td>
<td>FGF-21</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>FGF2 Expression Change</td>
</tr>
<tr>
<td class="label">Alzheimer's Disease</td>
<td>Increased (compensatory)</td>
</tr>
<tr>
<td class="label">Parkinson's Disease</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">ALS</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Stroke</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">318 edges</a></td>
</tr>
</table>
Pathway Diagram
Mermaid diagram (expand to render)
.infobox .infobox-protein
!!! Info
- Protein Name: Fibroblast Growth Factor 2 (Basic FGF)
- Gene: [FGF2](/genes/fgf2)
- UniProt: [P09038](https://www.uniprot.org/uniprot/P09038)
- PDB: [1bas](https://www.rcsb.org/structure/1bas), [2bfu](https://www.rcsb.org/structure/2bfu), [4oee](https://www.rcsb.org/structure/4oee)
- Molecular Weight: 17.2-18.0 kDa
- Subcellular Localization: Extracellular, Nucleus (internalization)
- Protein Family: FGF family, Heparin-binding growth factor
FGF-2 Protein (bFGF)
Overview
FGF2 (Fibroblast Growth Factor 2), also known as basic FGF (bFGF), is a member of the fibroblast growth factor family that plays critical roles in neuronal survival, development, and repair[@ornitz2015][@woodbury2014]. As a potent neurotrophic factor, FGF2 promotes neuronal survival, modulates neurogenesis, and exerts neuroprotective effects in models of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis), and stroke[@woodbury2014][@reuss2003][@goetz2013]. The protein's ability to promote neurogenesis, support synaptic plasticity, and protect against various forms of neuronal injury has made it a focus of extensive research for neurodegenerative disease therapeutics.
Protein Structure
Primary Structure
FGF2 is a 155-amino acid protein with a molecular weight of approximately 17-18 kDa[@ornitz2015][@woodbury2014]. The protein lacks a classical signal peptide but is secreted through unconventional secretory pathways. Multiple isoforms exist due to alternative translation initiation from different start codons, generating proteins ranging from 18-34 kDa[@ornitz2015][@woodbury2014].
Three-Dimensional Structure
The crystal structure of FGF2 reveals a characteristic beta-trefoil fold[@ornitz2015]:
- Beta-trefoil core: Twelve beta-strands arranged in a barrel-like structure
- Heparin-binding domain: Positively charged residues for heparin sulfate binding
- Receptor binding sites: Distinct regions for FGFR interaction
- Nuclear localization sequence: Contains nuclear import signals for internalization[@ornitz2015]
The heparin-binding domain is essential for:
- Dimerization and activation of FGF2
- Protection from proteolytic degradation
- Presentation to cell surface receptors
- Storage in the extracellular matrix[@ornitz2015][@woodbury2014]
Receptor Signaling
Fibroblast Growth Factor Receptors (FGFRs)
FGF2 signals through four main FGFRs (FGFR1-4), with FGFR1 being the primary receptor in neural tissue[@ornitz2015][@woodbury2014][@reuss2003]:
Signaling Pathways
FGF2 binding to FGFR triggers multiple downstream signaling cascades[@ornitz2015][@woodbury2014][@reuss2003]:
RAS/MAPK pathway: Primary pathway for cell proliferation and differentiation
PI3K/AKT pathway: Promotes cell survival and inhibits [apoptosis](/entities/apoptosis)
PLC-gamma pathway: Modulates calcium signaling and gene expression
STAT pathway: Involved in inflammatory responses[@ornitz2015][@woodbury2014]Normal Function in the CNS
Neurodevelopment
During CNS development, FGF2 plays essential roles[@ornitz2015][@woodbury2014]:
- Neurogenesis: Promotes proliferation of neural progenitor cells
- Neuronal differentiation: Guides differentiation into specific neuronal subtypes
- Axon guidance: Modulates growth cone behavior and axon pathfinding
- Synaptogenesis: Regulates formation and refinement of synaptic connections[@ornitz2015][@woodbury2014]
Adult Brain Function
In the adult brain, FGF2 continues to play important roles[@woodbury2014][@reuss2003]:
- Neurogenesis support: Maintains neural stem cells in the subventricular zone and dentate gyrus
- Synaptic plasticity: Modulates [long-term potentiation](/mechanisms/long-term-potentiation) and learning
- Astrocyte function: Regulates astrocyte proliferation and reactivity
- Neurovascular coupling: Affects blood flow regulation in response to neural activity[@woodbury2014][@reuss2003]
Neuroprotection
FGF2 exhibits broad neuroprotective properties[@woodbury2014][@reuss2003][@goetz2013]:
- Anti-apoptotic effects: Activates PI3K/AKT pathway to inhibit caspases
- Antioxidant properties: Upregulates antioxidant enzymes
- Calcium homeostasis: Modulates calcium signaling to prevent excitotoxicity
- Mitochondrial protection: Preserves mitochondrial function under stress[@woodbury2014][@reuss2003][@goetz2013]
Role in Neurodegenerative Diseases
Alzheimer's Disease
FGF2 has complex and multifaceted roles in AD pathophysiology[@woodbury2014][@reuss2003][@nakao2014]:
Neuroprotective effects:
- FGF2 protects against [amyloid-beta](/proteins/amyloid-beta) toxicity in neurons[@woodbury2014][@nakao2014]
- Promotes clearance of A-beta through modulation of microglial function
- Maintains synaptic integrity despite A-beta exposure
- Supports neurogenesis in the [hippocampus](/brain-regions/hippocampus), which is impaired in AD
Compensatory upregulation:
- FGF2 expression is increased in AD brain as a potential compensatory response
- Higher FGF2 levels correlate with slower cognitive decline in some studies
- Therapeutic potential: Exogenous FGF2 administration reduces AD-like pathology in models
Therapeutic challenges:
- Delivery across the [blood-brain barrier](/entities/blood-brain-barrier) remains challenging
- FGF2 promotes angiogenesis, which may have complex effects in AD
- Optimal dosing and timing need further investigation[@woodbury2014][@reuss2003][@nakao2014]
Parkinson's Disease
FGF2 provides neuroprotection in PD models through several mechanisms[@reuss2003][@goetz2013][@yoshimoto2005]:
- Dopaminergic neuron survival: FGF2 protects dopaminergic neurons from 6-OHDA and MPTP toxicity
- Neuroinflammation modulation: Reduces microglial activation and inflammatory cytokine production
- [Alpha-synuclein](/proteins/alpha-synuclein) effects: May modulate aggregation of alpha-synuclein
- Levodopa synergy: FGF2 enhances the effects of dopaminergic medications
Research shows that FGF2 delivery through viral vectors or protein administration improves motor function in PD models[@reuss2003][@goetz2013][@yoshimoto2005].
Amyotrophic Lateral Sclerosis
In ALS, FGF2 shows both protective and disease-modifying effects[@reuss2003][@goetz2013][@kwon2007]:
- Motor neuron protection: FGF2 promotes motor neuron survival in vitro
- Glial modulation: Modulates astrocyte and microglial responses
- Synaptic maintenance: Preserves neuromuscular junction integrity
- Neuroinflammation: Can have both pro- and anti-inflammatory effects
Clinical trials have explored FGF2 delivery in ALS, though results have been mixed due to delivery challenges and the complex nature of ALS pathogenesis[@reuss2003][@goetz2013].
Stroke and Ischemia
FGF2 is one of the most extensively studied neuroprotective factors in stroke[@reuss2003][@goetz2013][@goebel2018]:
- Ischemic injury protection: FGF2 reduces infarct size when administered before or after stroke
- Angiogenesis promotion: Stimulates formation of new blood vessels in the penumbra
- Neurogenesis induction: Promotes neurogenesis in the subventricular zone post-stroke
- Behavioral recovery: Improves functional outcomes in animal models
FGF2 has been investigated in clinical trials for acute stroke, though optimal delivery and timing protocols remain under development[@reuss2003][@goebel2018].
Therapeutic Applications
Protein Delivery
FGF2 protein can be delivered through various routes[@woodbury2014][@reuss2003][@goetz2013]:
- Intravenous administration: Requires penetration across the blood-brain barrier
- Intracerebral injection: Direct delivery to affected regions (invasive)
- Intranasal delivery: Non-invasive approach showing promise in models
- Exosome encapsulation: Novel approach to improve delivery and stability
Gene Therapy
Viral vector-mediated FGF2 delivery has been tested in preclinical models[@reuss2003][@goetz2013]:
- AAV vectors: Adeno-associated viruses for safe, long-term expression
- Lentiviral vectors: Integration for sustained FGF2 production
- Non-viral approaches: plasmid electrotransfer and nanoparticles
Combination Therapies
FGF2 shows synergy with other neuroprotective approaches[@woodbury2014][@reuss2003][@goetz2013]:
- With neurotrophic factors: GDNF, BDNF combinations
- With stem cells: Co-transplantation approaches
- With small molecules: Channel modulators, antioxidants
FGF Family in Neurodegeneration
Other FGF Family Members
The FGF family includes 22 ligands that signal through four FGFRs[@ornitz2015][@woodbury2014]:
FGF Signaling in Disease
Dysregulated FGF signaling is implicated in multiple neurodegenerative conditions[@woodbury2014][@reuss2003]:
- AD: Altered FGF receptor expression and downstream signaling
- PD: Reduced FGF2 responsiveness in dopaminergic neurons
- ALS: Dysregulated FGF expression in motor [cortex](/brain-regions/cortex) and spinal cord
- MS: FGF2 involved in remyelination and repair[@woodbury2014][@reuss2003]
Expression Changes in Disease
Research Directions
Current research areas include[@woodbury2014][@reuss2003][@goetz2013][@nakao2014][@yoshimoto2005]:
- Better delivery methods: Overcoming blood-brain barrier
- FGF2 mimetics: Small molecules that activate FGFR
- Combination approaches: Multi-target therapies
- Biomarker development: FGF2 as a biomarker for neurodegeneration
- Personalized medicine: Stratifying patients based on FGF2 pathway genetics
Novel Therapeutic Strategies
Modified FGF2 variants: Engineered proteins with enhanced neurotrophic activity
FGFR-selective agonists: Targeting specific FGFR subtypes
Intranasal formulations: Non-invasive delivery systems
Cell-penetrating peptides: Enhancing brain penetration[@woodbury2014][@reuss2003]Animal Models
Various animal models have been used to study FGF2 in neurodegeneration[@woodbury2014][@reuss2003][@goetz2013]:
- FGF2 knockout mice: Show increased vulnerability to neuronal injury
- Transgenic overexpression: Protective in various disease models
- Adenoviral delivery: Tested in stroke and PD models
- Humanized models: Testing human FGF2 in primate models
Disease-Specific Models
- AD models: 5xFAD and [APP](/entities/app-protein)/PS1 mice with FGF2 treatment
- PD models: MPTP-treated mice with FGF2 delivery
- ALS models: SOD1 transgenic mice with FGF2
- Stroke models: Middle cerebral artery occlusion with FGF2[@woodbury2014][@reuss2003][@goetz2013]
Cross-Linked Pathways
- [Neurotrophic factors](/mechanisms/neurotrophic-factors)
- [Neurogenesis](/mechanisms/neurogenesis)
- [Alzheimer's disease](/diseases/alzheimers-disease)
- [Parkinson's disease](/diseases/parkinsons-disease)
- [Amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Stroke](/diseases/stroke)
- [FGFR signaling](/mechanisms/fgfr-signaling)
- [Neuroinflammation](/mechanisms/neuroinflammation)
See Also
- [FGF2 Gene](/genes/fgf2)
- [Alzheimer's disease](/diseases/alzheimers-disease)
- [Parkinson's disease](/diseases/parkinsons-disease)
- [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Neurotrophic factors](/mechanisms/neurotrophic-factors)
- [Neurogenesis](/mechanisms/neurogenesis)
- [Amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Stroke](/diseases/stroke)
External Links
- [UniProt: P09038](https://www.uniprot.org/uniprot/P09038)
- [PDB structures](https://www.rcsb.org/search?q=uniprot:P09038)
- [GeneCards: FGF2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF2)
References
[Ornitz DM, Itoh N, The fibroblast growth factor signaling pathway (2015)](https://pubmed.ncbi.nlm.nih.gov/25772361/)
[Woodbury ME, Ikezu T, Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/23955711/)
[Reuss B, von Bohlen und Halbach O, Fibroblast growth factors and their receptors in the central nervous system (2003)](https://pubmed.ncbi.nlm.nih.gov/12845533/)
[Goetz R, Mohammadi M, How FGFs bind to FGFRs (2013)](https://pubmed.ncbi.nlm.nih.gov/23468115/)
[Nakao Y, et al, Fibroblast growth factor-2 in Alzheimer's disease (2014)](https://pubmed.ncbi.nlm.nih.gov/24530368/)
[Yoshimoto Y, et al, FGF-2 promotes dopaminergic neuron survival (2005)](https://pubmed.ncbi.nlm.nih.gov/15755548/)
[Kwon YW, et al, Fibroblast growth factor-2 in motor neuron disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17586483/)
[Goebel J, et al, FGF-2 therapy for stroke (2018)](https://pubmed.ncbi.nlm.nih.gov/29582925/)